HHC Drug-Test Evidence: Why the Library Match Matters

A spectral-library hit is a lead, not a finished identification. When a laboratory report involves hexahydrocannabinol (HHC), ask how the laboratory distinguished it from other cannabinoids, which reference material it used, and whether the chromatographic evidence agreed with the mass spectrum. A 2024 paper by Pitterl and colleagues provides a concrete example of why those questions matter.

AI-assisted editorial research, September 28, 2026. This educational analysis does not represent personal review or endorsement of the cited study by Okorie Okorocha. It is not legal advice, a case-specific opinion, or a comprehensive review of HHC pharmacology.

What the investigators actually examined

The researchers analyzed specimens from three people suspected of drug-impaired driving. They had plasma from all three and urine from two. This was casework-based analytical research, not a controlled dosing experiment or a study designed to establish a concentration associated with impaired driving. The distinction matters before applying any finding to a different person’s test.

The investigation combined a urine cannabinoid immunoassay, targeted gas chromatography-mass spectrometry (GC-MS), and non-targeted liquid chromatography with high-resolution tandem mass spectrometry (LC-MS/MS). The methods answered different questions. The evidence-review task is to follow the actual sequence, rather than collapse every result into the word “positive.” See the original paper’s methods and results.

The identification problem: HHC or cannabigerol?

The initial library search suggested cannabigerol, also called CBG, in the plasma specimens. The researchers tested a CBG reference standard under the same experimental conditions. Although the mass-spectral information looked similar, its chromatographic retention time did not agree. They rejected that identification.

They then tested an HHC reference standard. Both the mass-spectral and chromatographic information matched. Figure 2, on journal page 353, illustrates the similar fragmentation spectra that made the original candidate plausible. The authors explain that a library containing CBG spectra but lacking HHC spectra can return a misleading CBG candidate.

The practical lesson is specific: a candidate selected from the available library is not necessarily the correct compound. This example does not establish that every CBG report is wrong, that every HHC method fails, or that mass spectrometry is unreliable. It demonstrates the value of checking the proposed identity against independent chromatographic evidence and an appropriate reference standard.

Do not turn a screening result into a confirmed exposure history

Both urine specimens were positive on the study’s CEDIA THC immunoassay. The researchers discussed HHC-metabolite cross-reactivity as a possible explanation. But the non-targeted analysis also detected THC-COOH in the samples. That combination does not establish that HHC alone caused each screening response. Do not describe these two results as a measured HHC-specific false-positive rate.

The targeted plasma GC-MS results for THC-COOH were indeterminate because the ion ratios were outside the accepted ranges. The authors considered interference from related compounds plausible, but explicitly left the identity of the interfering material uncertain. An indeterminate result should not be silently converted into either a confirmed positive or a confirmed negative.

For counsel, the appropriate request is the assay-specific record: screening result, cutoff, confirmation result, acceptance criteria, and the laboratory’s explanation for any discrepancy. The paper is a reason to investigate the discrepancy, not a substitute for that investigation.

The specimen and the named analyte change the question

Table I, on journal page 356, reports parent HHC in the three plasma specimens but not in the two urine specimens. HHC-related metabolites were reported in urine. Those are observations from this small case series, not universal detection windows and not proof that parent HHC can never be found in urine.

The table also distinguishes proposed metabolite assignments. The authors acknowledged uncertainty about some structures and the precise positions of chemical modification. Do not translate a tentative research annotation into an unequivocal identification in another laboratory’s report. Ask whether that laboratory measured parent HHC, a particular metabolite, or only a broad cannabinoid screening response, and how it established the specificity of that marker.

The associated cannabis and THC toxicology resource provides background on specimen-specific interpretation. It is a general reading path, not independent validation of an HHC result.

Records to request for an HHC identification

The following is an editorial checklist drawn from the identification problem in this paper. It is not a claim that a missing document automatically invalidates a result.

1. The exact reported substance. Obtain the full analyte name, specimen type, units if quantified, reporting threshold, and whether the result was presumptive, confirmed, indeterminate, or tentative.
2. The library and its contents. Request the library name and version used at the time, the candidate matches, and documentation showing whether HHC and relevant alternatives were represented. A later library update does not show what the original search contained.
3. Reference-material records. Identify the material used to support the reported identity, its certificate and lot, and whether its chemical form matched the claimed analyte.
4. The chromatographic comparison. Obtain the sample and reference-standard chromatograms, retention-time acceptance rules, integration records, and explanations for any mismatch or unresolved peak.
5. The mass-spectral comparison. Request the underlying spectra, identification criteria, ion-ratio or mass-accuracy requirements, review notes, and the treatment of competing candidates. A screenshot showing only the top library hit leaves important questions unanswered.
6. The analytical batch. Obtain relevant blanks, controls, system-suitability records, repeats, and the laboratory’s method-validation material for the specimen and analytes involved. The study used quality controls; it does not validate a different laboratory’s procedure.
7. The interpretive timeline. Keep the event time, collection time, storage history, reported product history, and analysis time separate. Record what is known, what is reported, and what remains uncertain.

Identification is not a driving-time impairment opinion

Even a well-supported identification does not, by itself, establish the dose, exact time of use, specific commercial product, or impairment during a particular event. This paper did not establish a universal HHC concentration threshold or a safe-driving waiting period. Suspicion of impaired driving was the context in which the specimens were collected, not a controlled demonstration that a particular laboratory finding caused the observed behavior.

Keep the laboratory question separate from the clinical and driving evidence. The existing four-question cannabis evidence framework distinguishes exposure, recency, impairment, and crash causation. This HHC guide addresses an earlier step: whether the proposed chemical identity has been adequately supported.

Source and review scope

Pitterl F, Pavlic M, Liu J, Oberacher H. Insights into the human metabolism of hexahydrocannabinol by non-targeted liquid chromatography-high-resolution tandem mass spectrometry. Journal of Analytical Toxicology. 2024;48(5):350-358. doi:10.1093/jat/bkae022. PubMed record.

This focused editorial review covered the nine-page published paper, including its references, and the five-page PDF supplement describing GC-MS and additional reference-standard analyses. The figures and Table I were inspected. The source’s underlying case data were not independently reanalyzed. Later HHC studies exist; this page does not claim to settle the complete or current pharmacokinetics of HHC. No source PDF, patient record, or copyrighted figure is reproduced here.